Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$300.57 - $336.42 $73.4 Million - $82.1 Million
-244,126 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$244.61 - $310.48 $9.25 Million - $11.7 Million
-37,811 Reduced 13.41%
244,126 $74.7 Million
Q4 2021

Feb 14, 2022

BUY
$198.21 - $248.9 $16.9 Million - $21.2 Million
85,254 Added 43.35%
281,937 $70.1 Million
Q3 2021

Nov 15, 2021

BUY
$188.42 - $208.66 $5.47 Million - $6.06 Million
29,031 Added 17.32%
196,683 $39.2 Million
Q4 2020

Feb 16, 2021

SELL
$143.79 - $183.66 $1.52 Million - $1.95 Million
-10,591 Reduced 5.94%
167,652 $29.2 Million
Q3 2020

Nov 16, 2020

BUY
$140.89 - $159.9 $2.93 Million - $3.33 Million
20,819 Added 13.22%
178,243 $26.5 Million
Q2 2020

Aug 14, 2020

BUY
$125.49 - $164.68 $19.8 Million - $25.9 Million
157,424 New
157,424 $24.2 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $90.3B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Alyeska Investment Group, L.P. Portfolio

Follow Alyeska Investment Group, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.